Back to Portfolio
AMPX

Amprius Technologies

$21.73 3.1B market cap April 2026
Amprius Technologies Inc. AMPX BUFFETT / MUNGER / KLARMAN SUMMARY
1 SNAPSHOT
Price$21.73
Market Cap3.1B
2 BUSINESS

Amprius Technologies represents a genuine technology breakthrough in battery energy density (2x conventional Li-ion) with real commercial traction ($73M revenue, 202% growth, first positive adjusted EBITDA). The defense positioning via NDAA-compliant silicon anode batteries for drones and UAVs creates meaningful switching costs and incumbency advantages. However, at $21.73 (42x trailing P/S, 30x P/B), the market is pricing in the bull case while the company remains pre-profitability with negative FCF, a $218M accumulated deficit, 61% share dilution over 3 years, and active insider selling. Battery technology has a long history of failed promises at manufacturing scale (A123, Fisker, QuantumScape). The honest assessment is that AMPX is a legitimate technology option -- not a value investment -- and should be purchased only at prices that compensate for the substantial probability of permanent capital loss. Wait for a 45%+ pullback to accumulate at $12 or below.

3 MOAT NARROW

Silicon anode IP (80+ patents from Stanford spinout), 2x energy density vs conventional Li-ion (500 Wh/kg SiMaxx, 450 Wh/kg SiCore), NDAA-compliant defense supplier with platform incumbency and 2-3 year requalification switching costs

4 MANAGEMENT
CEO: Tom Stepien (since Jan 2026)

Good - Pivoted from capital-heavy factory (Brighton, CO) to capital-light contract manufacturing. Eliminated $110M+ in lease obligations. Smart strategic shift. But $71M in equity financing in 2025 = ongoing shareholder dilution.

5 ECONOMICS
-11.7% Op Margin
-28.1% ROIC
-50.8% ROE
-0.036B FCF
-83% Debt/EBITDA
6 VALUATION
FCF Yield-1.1%
DCF Range12 - 20

Overvalued by 31% vs probability-weighted fair value of $16.55

7 MUNGER INVERSION
Kill Event Severity P() E[Loss]
Extreme valuation (42x P/S) on pre-profitability company with battery technology execution risk HIGH - -
61% share dilution in 3 years, insider selling at $12-19, customer concentration in defense programs MED - -
8 KLARMAN LENS
Downside Case

Extreme valuation (42x P/S) on pre-profitability company with battery technology execution risk

Why Market Right

Revenue miss on $125M 2026 guidance would destroy narrative; Gross margin regression as SiCore volume pricing compresses; Dilutive equity raise despite $90M cash (signals worse-than-expected burn); Competitive silicon anode product from CATL/Samsung SDI/Sila achieving comparable density; Solid-state battery breakthrough leapfrogging silicon anode technology entirely

Catalysts

Q1 2026 earnings (May 2026) -- continued margin improvement and revenue acceleration toward $125M guide; Pentagon $75B drone budget request -- positions AMPX as critical NDAA-compliant battery supplier; eVTOL / commercial aviation design wins expanding TAM beyond defense; Positive FCF quarter would validate path to self-funding; Potential M&A target for large battery or defense conglomerate

9 VERDICT WAIT
C+ Quality Moderate - $90.5M cash, no debt, 3-4 year runway at current burn, but still FCF negative with $218M accumulated deficit. Capital-light contract manufacturing pivot reduces future funding needs.
Strong Buy$8
Buy$12
Fair Value$20

Monitor Q1 2026 earnings (May 2026). Set alerts at $12 (accumulate) and $8 (strong buy). Do not chase momentum at $21+.

🧠 ULTRATHINK Deep Philosophical Analysis

Amprius Technologies (AMPX) - Deep Philosophical Analysis

An exercise in thinking about technology options, battery graveyards, and the difference between what is possible and what is profitable.

The Core Question: Is This a Battery or a Business?

Every decade produces a new battery technology that will "change everything." In the 2000s it was A123 Systems with lithium iron phosphate. In the 2010s it was Envia Systems with manganese-rich cathodes, then Fisker with solid-state promises, then QuantumScape with ceramic separators. Each generated breathless headlines, billions in investment, and ultimately disappointment at manufacturing scale.

Now comes Amprius Technologies with silicon anode batteries that genuinely deliver 500 Wh/kg -- nearly double the energy density of conventional lithium-ion cells. The physics works. The product ships. Real drones fly farther because of these batteries. This is not vaporware.

And yet the central question persists: is this a battery -- meaning a component in someone else's product -- or a business -- meaning an entity that can sustainably generate returns on invested capital above its cost of capital?

Buffett would ask it more simply: would I want to own 100% of this company at this price, collect whatever cash it produces, and never sell?

At $3.1 billion for a company generating $73 million in revenue, negative free cash flow, and an accumulated deficit of $218 million, the answer today is unambiguously no.

Moat Meditation: The Paradox of Premium Batteries

Amprius occupies a peculiar competitive position. Its batteries are the best in the world by one critical metric -- gravimetric energy density -- and yet this superiority creates a strategic paradox.

The applications where 500 Wh/kg matters most are inherently niche. High-altitude long-endurance drones. Satellite power systems. Certain eVTOL configurations. These are markets measured in hundreds of millions, not tens of billions. The mass market -- electric vehicles, grid storage, consumer electronics -- optimizes for cost per kilowatt-hour, not watts per kilogram. A Tesla Model Y buyer cares about range-per-dollar. A HALE drone operator cares about grams-per-watt-hour.

This creates what I call the "premium battery trap." You are the best, but the best serves a small market. You can broaden your market (via SiCore at 400 Wh/kg, cheaper to manufacture) but then you compete more directly with CATL, Samsung SDI, and LG Energy Solution -- organizations with R&D budgets larger than Amprius's entire market capitalization.

The defense angle partially resolves this trap. NDAA compliance, platform qualification, and MIL-SPEC switching costs create a moat within the moat -- a defensible niche where being American-sourced matters as much as being energy-dense. But defense revenue is lumpy, slow-moving, and subject to political winds. The Pentagon's $75 billion drone request is exciting until the next budget sequestration or program cancellation.

The honest durability assessment: Amprius has perhaps a 5-7 year window where its silicon anode technology lead provides meaningful differentiation. After that, the large Asian manufacturers will likely achieve 80-90% of AMPX's energy density at a fraction of the cost. The question is whether AMPX can convert its temporary technology advantage into permanent customer relationships and manufacturing scale before the window closes.

The Owner's Mindset: Would Buffett Hold This for 20 Years?

He would not. Let us be honest about that.

Buffett has been clear about what he avoids: businesses where the technology changes rapidly, where competitive advantages depend on continuous innovation, where capital requirements are uncertain, and where the range of outcomes is binary. Amprius checks every one of those boxes.

More fundamentally, Buffett invests in businesses that have already proven they can generate sustainable free cash flow. AMPX has never generated positive free cash flow in any year of its existence. The cumulative operating cash outflow since 2020 exceeds $117 million. The path to profitability is visible -- management guides near-breakeven for 2026 -- but "visible" and "proven" are different words.

However, there is a Munger-esque mental model that applies here: the venture-style option position within a value portfolio. Munger himself has acknowledged that some of Berkshire's best investments involved paying up for quality and letting the business compound. And Li Lu, Munger's protege, has invested in deeply uncertain Chinese technology companies when the risk/reward was asymmetric.

The Munger question is not "would I hold this forever" but "is the expected value of this bet positive after accounting for the probability of permanent capital loss?" At $21.73, the answer is unclear. At $8-12, the answer becomes more compelling.

Risk Inversion: What Destroys This Business?

Working backwards from failure, as Munger would advise:

Death by Dilution. This is the most probable failure mode. Cash burn of $30-35M per year, even improving, requires periodic equity raises. Shares outstanding have grown 61% in three years. If revenue growth stalls or margins disappoint, the company enters the death spiral: lower stock price -> worse terms on equity raises -> more dilution -> lower stock price. Many promising battery companies have died this way. A123 Systems raised over $600 million before bankruptcy.

Death by Competition. CATL's R&D budget alone exceeds $3 billion per year. Samsung SDI, LG Energy, Panasonic -- these are organizations that can simply outspend AMPX to replicate silicon anode performance. The question is timing: can AMPX build enough customer lock-in before the giants arrive? History suggests the answer is usually no. The small innovator proves the concept, the large manufacturer scales it.

Death by Technology Shift. Solid-state batteries, if they work, offer even higher energy density than silicon anodes. Toyota claims 2027-2028 production timelines. Lithium-metal anodes offer theoretical advantages. If any alternative chemistry achieves 500+ Wh/kg with better cycle life at scale, AMPX's entire value proposition evaporates.

Death by Customer Concentration. A single canceled defense program or a delayed drone procurement could eliminate 20-30% of revenue overnight. Defense markets are not like consumer markets -- there is no long tail of thousands of small customers providing resilience. There is the Pentagon and its prime contractors, and if they shift priorities, you shift with them or you die.

Death by the Curse of Almost. Perhaps the most insidious risk. The company grows revenue to $150M, then $200M. Gross margins stabilize at 15-20%. But operating expenses consume the gross profit. The company is perpetually "almost" profitable, "almost" FCF positive. The stock trades sideways for years. Early investors who bought at $2-5 have done well. Anyone buying at $20+ watches their capital stagnate. This is actually the most likely "failure" mode -- not spectacular bankruptcy, but slow value destruction through dilution and mediocre returns.

Valuation Philosophy: The Option Framework

Traditional DCF is meaningless for a company with negative cash flows and a 30% probability of going to near-zero. Instead, think of AMPX as a portfolio of real options:

Option 1: Defense Battery Incumbency (intrinsic value: $800M-1.5B). If AMPX maintains its NDAA-compliant position and defense revenue grows to $80-100M with 25%+ margins, this option alone justifies a $6-11 per share valuation.

Option 2: Commercial Aviation / eVTOL (time value: $500M-2B). If SiCore achieves design wins in eVTOL platforms (Joby, Archer, Lilium successors), the TAM expands dramatically. But this is 3-5 years away and uncertain.

Option 3: Acquisition Target (probability-weighted: $300M-500M). If Amprius demonstrates technology leadership but struggles to scale independently, a large battery manufacturer or defense company acquires the IP and customer relationships. This puts a floor under the stock at roughly $3-8 per share.

The sum of these options, probability-weighted, yields roughly $16-17 per share. At $21.73, you are paying a 30% premium for time value that may or may not materialize.

The Patient Investor's Path

The right framework for AMPX is not "buy or don't buy." It is "at what price does the risk/reward become asymmetric in my favor?"

At $21.73: You are paying bull-case prices for a company that has not yet proven base-case economics. The insiders selling at $12-19 are telling you something -- they know the technology better than any outside investor, and they are taking money off the table.

At $12: You are paying roughly probability-weighted fair value with a small margin of safety. The defense option alone provides a floor, and the commercial upside comes "free."

At $8: You are paying bear-case value while retaining exposure to base, bull, and moonshot outcomes. This is where the Kelly criterion would suggest a small position (1-2% of portfolio).

The patience required is real. AMPX traded at $1.97 twelve months ago. It may trade there again if a single defense contract slips or a single quarter disappoints. The battery technology investor's graveyard is full of people who bought the narrative at the top and sold the disappointment at the bottom.

The disciplined approach: set price alerts at $12 and $8. Wait. If the stock never gets there because the company executes flawlessly and grows into its valuation -- you miss it, and that is acceptable. Missing an uncertain binary bet is not a sin. Overpaying for one is.

In the words of Buffett: "The stock market is a device for transferring money from the impatient to the patient." With AMPX, patience means waiting for the market to price in the risks that are currently being ignored in the euphoria of tripling revenue and Pentagon drone budgets.

The technology is real. The execution is improving. The valuation is not yet right.

Wait.

Executive Summary

Amprius Technologies is a Stanford University spinout (founded 2008 by Dr. Yi Cui) that manufactures silicon anode lithium-ion batteries with the highest commercially available energy density (500 Wh/kg SiMaxx, ~450 Wh/kg SiCore). The company tripled revenue to $73M in 2025, achieved its first positive adjusted EBITDA quarter (Q4 2025: $1.8M), and guides to $125M+ revenue in 2026 with near-breakeven profitability. AMPX is not a traditional value investment -- it is an option on the commercialization of a genuinely differentiated deep technology with defense-first market positioning.

Verdict: WAIT -- compelling technology and execution trajectory, but $3.1B market cap on $73M revenue (42x P/S) prices in significant future success. Need 50%+ pullback for adequate margin of safety.

Phase 1: Risk Assessment

Critical Risks (Red Flags)

  1. Extreme Valuation vs. Fundamentals

    • Price-to-Sales: 42.6x trailing, ~25x on 2026 guidance
    • Price-to-Book: 30.0x
    • EV/Revenue: 42.5x
    • No earnings, no dividends, negative cumulative cash flow
    • Market cap ($3.1B) = 42x trailing revenue, 25x forward revenue

  2. Persistent Cash Burn and Dilution

    • Cumulative operating cash outflow: -$117M over 2020-2025
    • FY2025 operating cash flow: -$31.1M
    • Financing activities in 2025: +$71M (equity raises)
    • Share count growth: 85M (2022) -> 102M (2024) -> 137M (current) = 61% dilution in 3 years
    • Stock-based compensation: $7.4M in 2025 (10% of revenue)
    • Accumulated deficit: -$218M

  3. Insider Selling Pattern

    • Founder-connected director Kang Sun sold 1.5M+ shares in March-April 2026 at $15-19
    • Nobel laureate Steven Chu exercised options and sold 316K shares at $17-19 in March 2026
    • CTO Constantin Stefan sold 492K+ shares at $12 in January 2026
    • Pattern: insiders exercising options at low strike prices and selling into strength
    • CEO Stepien and CFO Rodriguez received RSU grants (150K each) in March 2026

  4. Technology Risk: Battery Industry Graveyard

    • A123 Systems: filed bankruptcy 2012 despite promising technology
    • Fisker: bankrupt 2023
    • QuantumScape: still pre-revenue after $1B+ invested in solid-state
    • Solid Power: minimal revenue, ongoing R&D phase
    • Battery technology has a long history of lab success that fails at manufacturing scale
    • Silicon anode degradation during cycling remains an unsolved fundamental challenge

  5. Customer Concentration and Defense Dependency

    • Revenue heavily concentrated in defense/aerospace (drones, UAVs, HALE systems)
    • Key customers appear to include AeroVironment, Airbus, defense primes
    • DIU (Defense Innovation Unit) contract: $14.8M
    • $35M unmanned aerial systems order
    • Pentagon budget cycles are unpredictable; programs get cancelled
    • Defense procurement timelines are notoriously slow and non-linear

  6. Manufacturing Scale-Up Risk

    • Shifted to capital-light contract manufacturing model (Korea Battery Alliance, 2+ GWh)
    • Terminated 15-year Brighton, Colorado lease ($20M termination, $22.5M impairment)
    • Contract manufacturing = less control over quality, IP exposure, margin compression
    • Korean partners are building to AMPX specifications -- if volume disappoints, excess capacity
    • First US-based manufacturing partner recently added (NDAA compliance)
    • Actually using only 30-40% of contracted 2.0 GWh capacity for 2026 guidance

Moderate Risks

  1. Competition from Multiple Vectors

    • CATL, BYD, Samsung SDI, LG Energy: massive R&D budgets, silicon-blend anodes in development
    • Solid-state batteries (Toyota, QuantumScape): if they work, they leapfrog silicon anodes
    • Lithium-metal anodes: higher theoretical energy density
    • Sila Nanotechnologies: silicon anode competitor, Mercedes partnership
    • Group14 Technologies: silicon anode materials supplier, Porsche partnership

  2. Narrow End-Market Application

    • 500 Wh/kg batteries are premium-priced, limiting addressable market
    • Primary demand from aviation/drones where energy density is mission-critical
    • Mass-market EV batteries optimize for cost/kWh, not Wh/kg
    • SiCore (400 Wh/kg, cheaper) broadens addressable market but faces more competition

  3. Management Transition

    • New CEO Tom Stepien (effective Jan 2026) -- former CEO of South 8 Technologies
    • New CFO Ricardo Rodriguez (effective Oct 2025) -- formerly of Aspen Aerogels
    • Founder Dr. Yi Cui is Stanford academic, not operator
    • Previous CEO Kang Sun retired, now advisor/director -- selling shares

Phase 2: Financial Analysis

Revenue Trajectory

Year Revenue YoY Growth Gross Profit Gross Margin
2020 $4.7M - -$2.0M -43%
2021 $2.8M -41% -$4.3M -156%
2022 $4.4M +59% -$5.4M -123%
2023 $8.8M +100% -$14.9M -170%
2024 $24.2M +175% -$18.3M -76%
2025 $73.0M +202% $8.3M +11%
2026E $125M+ +71%+ ~$25-30M ~20-24%

Revenue growth is genuinely impressive: from $4.4M to $73M in three years. The inflection from negative to positive gross margins in 2025 is the critical proof point. Q4 2025 achieved 24% gross margin -- this demonstrates unit economics can work at scale.

Quarterly Margin Trajectory (Critical)

Quarter Revenue Gross Margin Operating Loss Adj. EBITDA
Q1 2025 $11.3M -21% -$9.7M -
Q2 2025 $15.1M +9% -$6.8M -
Q3 2025 $21.4M +15% -$4.7M -
Q4 2025 $25.2M +24% -$2.9M +$1.8M

The margin trajectory is the most encouraging data point. Each quarter showed sequential improvement. Q4 adjusted EBITDA turned positive for the first time. If this continues in 2026 at $125M+ revenue with 20-24% gross margins, near-breakeven is plausible.

Cash Position and Burn Rate

Metric 2023 2024 2025
Cash & Equivalents $45.8M $55.2M $90.5M
Operating Cash Flow -$25.6M -$33.4M -$31.1M
CapEx $17.6M $3.2M $4.4M
Free Cash Flow -$43.1M -$36.6M -$35.5M
Financing Inflows $19.2M $47.2M $71.0M

Cash position actually improved to $90.5M thanks to $71M in financing (equity issuances). Operating burn improved slightly despite tripling revenue, reflecting the capital-light contract manufacturing pivot.

2026 Cash Runway Analysis:

  • Cash at year-end 2025: $90.5M
  • 2026 guided net loss: <$8M
  • 2026 guided CapEx: <$10M
  • Estimated 2026 cash burn: $15-25M (improved operating leverage)
  • Implied year-end 2026 cash: $65-75M
  • Runway: ~3-4 years at current burn trajectory without additional raises

The Brighton lease termination eliminated $110M+ in future lease obligations -- a smart capital-light pivot.

Balance Sheet

Metric 2025
Total Assets $156.9M
Cash $90.5M
Receivables $23.7M
Inventory $6.7M
Total Equity $103.8M
Lease Obligations $39.9M
Accumulated Deficit -$218.4M
Book Value/Share $0.77
Net Debt (ex-leases) Net cash ~$86M

The company is in a net cash position excluding operating leases. No traditional debt. The balance sheet is adequate for a pre-profitability growth company but provides no fortress-quality protection.

Earnings Per Share Trajectory

Year EPS (GAAP) EPS (Adj.)
2022 -$0.16 -
2023 -$0.43 -
2024 -$0.44 -
2025 -$0.35 -$0.17
2026E <-$0.06 Near breakeven

The improving EPS trajectory is real. Q4 2025 adjusted EPS was -$0.01. Four consecutive quarters of earnings beats vs. estimates in 2025.

Phase 3: Moat Assessment

The Silicon Anode Advantage (What is Real)

AMPX's core technology claim is legitimate: silicon anodes can theoretically store ~10x more lithium per unit weight than graphite anodes. The physics is real. The engineering challenge is that silicon expands ~300% during lithiation, causing electrode cracking and rapid capacity fade.

Two Product Lines:

  1. SiMaxx: 100% silicon nanowire anodes, 500 Wh/kg, 1,300 Wh/L -- highest energy density commercially available. Used for premium defense/aerospace applications.
  2. SiCore: Proprietary silicon material system, ~400-450 Wh/kg, 1,150 Wh/L -- easier to manufacture with standard equipment, primary product for 2026 revenue ramp.

For context: conventional lithium-ion (Tesla/Panasonic NCA cells) achieves ~260 Wh/kg. AMPX delivers nearly 2x the energy density. This is not incremental -- it is a step-change that enables applications like HALE drones, eVTOL, and satellite power systems that are simply impossible with conventional batteries.

IP and Patent Portfolio

  • 80+ granted patents globally
  • Core patents cover: vapor deposition processes, silicon nanowire structures, electrolyte formulations
  • Stanford University origin (Dr. Yi Cui's lab) provides academic credibility
  • Nobel laureate Steven Chu on board (former US Secretary of Energy)

Honest Assessment: The patent portfolio is meaningful but narrow. It protects specific manufacturing processes, not the fundamental concept of silicon anodes. Large battery manufacturers (CATL, Samsung SDI) are developing their own silicon anode approaches that work around AMPX's specific patents. The IP moat is real but time-limited -- perhaps 5-7 years before alternative approaches achieve comparable energy density.

Defense Market Positioning (Strongest Moat Element)

  • NDAA Compliance: Batteries manufactured in NDAA-compliant supply chain (Korea Battery Alliance, new US partner)
  • Qualified Supplier: Already qualified with Pentagon drone programs, DIU contracts
  • Sole Source Risk = Incumbency Advantage: Once a battery is qualified for a specific defense platform, the switching cost is enormous (2-3 year requalification cycle)
  • 550+ Customers: Broad engagement across defense, aerospace, commercial
  • Key Wins: AeroVironment, Nordic Wing (European ISR drones), Nokia Drone Networks, unnamed defense primes
  • Pentagon's $75B Drone Budget Request: CEO Stepien publicly cited this as tailwind (CNBC, April 2026)

Honest Assessment: Defense incumbency is the most durable competitive advantage. Once a battery is designed into a drone platform and passes MIL-SPEC qualification, it is extremely difficult to replace. However, this cuts both ways -- defense programs are slow, budgets shift, and customer concentration creates revenue volatility.

Manufacturing Strategy (Capital-Light Pivot)

The shift from building its own factory (Brighton, Colorado) to contract manufacturing (Korea Battery Alliance, 2+ GWh) is strategically smart:

  • Reduces capital intensity (2026E CapEx <$10M vs. $17.6M in 2023)
  • Leverages Korean battery manufacturing expertise
  • Enables faster capacity scaling
  • But sacrifices some margin and quality control

Currently using only 30-40% of contracted 2.0 GWh capacity. This means 2026 revenue of $125M+ is achievable without additional manufacturing investment.

Moat Width: NARROW and Uncertain

Moat Factor Rating Notes
IP/Patents Moderate 80+ patents, but alternatives being developed
Energy Density Lead Strong 2x conventional, but lead may narrow in 5-7 years
Defense Qualification Strong NDAA compliance, platform incumbency
Manufacturing Scale Weak Contract manufacturing, no proprietary facilities
Brand/Reputation Moderate Stanford pedigree, Nobel laureate board member
Cost Advantage None Premium-priced product
Switching Costs Strong (Defense) / Weak (Commercial) High for qualified defense platforms
Network Effects None No network dynamics

Overall Moat: NARROW -- primarily based on technology lead and defense incumbency, both time-limited

Phase 4: Synthesis and Valuation

This is an Option, Not a Stock

AMPX cannot be valued using traditional methods (DCF, P/E, dividend discount). It must be valued as a technology option with probability-weighted scenarios.

Scenario Analysis

Bear Case (30% probability): Technology Stalls or Competition Catches Up

  • Revenue growth decelerates as defense programs plateau
  • Gross margins stagnate at 10-15% as competition intensifies
  • Cash burn continues, requiring dilutive raises
  • Market cap: $500M-1B (75-85% downside)
  • Share price: $3-7

Base Case (45% probability): Steady Growth, Niche Leadership

  • Revenue reaches $200-300M by 2028, achieving sustainable profitability
  • Gross margins stabilize at 25-30%
  • Maintains defense incumbency, SiCore gains commercial traction
  • Modest but ongoing dilution
  • Fair value on 8-10x 2028 revenue: $1.6-3.0B
  • Share price: $10-18

Bull Case (20% probability): Breakout to Mass Market

  • SiCore achieves cost parity for eVTOL/commercial aviation
  • Revenue exceeds $500M by 2029
  • 30%+ gross margins, profitable at operating level
  • Defense + commercial aviation + EV premium applications
  • Fair value on 6-8x 2029 revenue: $3.0-4.0B+
  • Share price: $20-30+

Moonshot Case (5% probability): Category Creator

  • Silicon anode becomes dominant next-gen architecture
  • AMPX as the enabling platform company
  • Revenue $1B+, CATL/Samsung SDI acquisition target
  • Market cap: $8-15B
  • Share price: $50-100+

Probability-Weighted Fair Value

Scenario Probability Value/Share Weighted
Bear 30% $5.00 $1.50
Base 45% $14.00 $6.30
Bull 20% $25.00 $5.00
Moonshot 5% $75.00 $3.75
Weighted Average $16.55

Current price: $21.73 -- trading ~31% ABOVE probability-weighted fair value.

Entry Price Framework

Level Price P/S (2026E) Logic
Strong Buy $8.00 ~9x 50%+ discount to prob-weighted FV, prices in bear case
Accumulate $12.00 ~13x ~27% discount to prob-weighted FV, margin of safety
Fair Value $16.50 ~18x Probability-weighted expected value
Current $21.73 ~24x 31% premium to fair value, prices in bull case

Why Not Now?

At $21.73, you are paying for the bull case while absorbing bear case risk. The stock has already risen from $1.97 (52-week low) to $22.80 (52-week high) -- an 11x move. The positive narrative is fully priced in.

What Would Change the Thesis?

Upgrade triggers:

  • 2-3 consecutive quarters of positive FCF (not just adjusted EBITDA)
  • Gross margins sustaining above 25%
  • Major non-defense commercial contract (eVTOL platform win, consumer electronics)
  • Share count stabilization (no more dilutive raises)
  • Insider buying (not just option exercises)

Downgrade triggers:

  • Revenue miss on 2026 $125M guidance
  • Gross margin regression below 15%
  • Additional equity raise at dilutive terms
  • Key defense contract cancellation
  • Competitive product launch achieving comparable Wh/kg at lower cost

Verdict

WAIT at $21.73. Compelling technology and execution, but valuation prices in success that has not yet been proven.

For a value-oriented portfolio:

  • Strong Buy: $8.00 (provides margin of safety for bear case)
  • Accumulate: $12.00 (meaningful discount to probability-weighted fair value)
  • Monitor Q1 2026 earnings (May 2026) and full-year 2026 execution

Position sizing note: Even at entry prices, AMPX warrants only 1-2% portfolio allocation as a deep-tech option position. This is not a compounder. It is a binary/ternary outcome bet on technology commercialization.

Analysis based on: 10-K FY2025, Q4 2025 earnings release, AlphaVantage financial data, company IR disclosures, SEC insider transaction filings. No analyst reports used.